{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:50:19Z","timestamp":1790772619630,"version":"4.1.0"},"reference-count":156,"publisher":"Bentham Science Publishers Ltd.","issue":"01","license":[{"start":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:00:00Z","timestamp":1269907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["openrespiratorymedicinejournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TORMJ"],"published-print":{"date-parts":[[2010,3,30]]},"abstract":"<jats:p>Cystic Fibrosis (CF) is the most common fatal inherited disease of Caucasians, affecting about 1 in 3000 births. Patients with CF have a recessive mutation in the gene encoding the CF transmembrane conductance regulator (CFTR). CFTR is expressed in the epithelium of many organs throughout the exocrine system, however, inflammation and damage of the airways as a result of persistent progressive endobronchial infection is a central feature of CF. The inflammatory response to infection brings about a sustained recruitment of neutrophils to the site of infection. These neutrophils release various pro-inflammatory compounds including proteases, which when expressed at aberrant levels can overcome the endogenous antiprotease defence mechanisms of the lung. Unregulated, these proteases can exacerbate inflammation and result in the degradation of structural proteins and tissue damage leading to bronchiectasis and loss of respiratory function. Other host-derived and bacterial proteases may also contribute to the inflammation and lung destruction observed in the CF lung. Antiprotease strategies to dampen the excessive inflammatory response and concomitant damage to the airways remains an attractive therapeutic option for CF patients.<\/jats:p>","DOI":"10.2174\/1874306401004020020","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T17:14:13Z","timestamp":1270660453000},"page":"20-31","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis"],"prefix":"10.2174","volume":"04","author":[{"given":"Derek J","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/adc.68.3.389","volume":"68","author":"Greally PM","year":"1993","unstructured":"Greally PM, Hussein MJ, Cook AJ, Sampson AP, Piper PJ, Price JF. \n            Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis \n            Arch Dis Child  \n            1993; \n            68\n            : 389-92.","journal-title":"Arch Dis Child"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1164\/ajrccm.152.6.8520783","volume":"152","author":"Bonfield TL","year":"1995","unstructured":"Bonfield TL, Panuska JR, Konstan MW, et al. \n            Inflammatory cytokines in cystic fibrosis lungs \n            Am J Respir Crit Care Med  \n            1995; \n            152\n            : 2111-18.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR3","doi-asserted-by":"crossref","first-page":"L688","DOI":"10.1152\/ajpcell.00586.2001","volume":"283","author":"Strieter RM","year":"2002","unstructured":"Strieter RM. \n            Interleukin-8: a very important chemokine of the human airway epithelium \n            Am J Physiol  \n            2002; \n            283\n            : L688-9.","journal-title":"Am J Physiol"},{"key":"refR4","first-page":"3","volume":"40","author":"Birrer P","year":"1993","unstructured":"Birrer P. \n            Consequences of unbalanced protease in the lung: protease involvement in destruction and local defence mechanisms of the lung \n            Agents Actions Suppl  \n            1993; \n            40\n            : 3-12.","journal-title":"Agents Actions Suppl"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1172\/JCI114492","volume":"85","author":"Sommerhoff CP","year":"1990","unstructured":"Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. \n            Neutrophil elastase and cathepsin G stimulate secretion from bovine airway gland serous cells \n            J Clin Invest  \n            1990; \n            85\n            : 682-89.","journal-title":"J Clin Invest"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/01902149309031724","volume":"19","author":"Breuer R","year":"1993","unstructured":"Breuer R, Christensen TG, Lucey EC, Bolbochan G, Stone PJ, Snider GL. \n            Elastase causes secretory discharge in bronchi of hamsters with elastase-induced secretory cell metaplasia \n            Exp Lung Res  \n            1993; \n            19\n            : 273-82.","journal-title":"Exp Lung Res"},{"key":"refR7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1665","volume":"148","author":"O'Connor CM","year":"1993","unstructured":"O'Connor CM, Gaffney K, Keane J, et al. \n            \u03b11-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis \n            Am Rev Respir Dis  \n            1993; \n            148\n            : 1665-70.","journal-title":"Am Rev Respir Dis"},{"key":"refR8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.biocel.2008.02.002","volume":"40","author":"Jacquot J","year":"2008","unstructured":"Jacquot J, Tabary O, Le Rouzic P, Clement P. \n            Airway epithelial cell inflammatory signaling in cystic fibrosis \n            Int J Biochem Cell Biol  \n            2008; \n            40\n            : 1703-5.","journal-title":"Int J Biochem Cell Biol"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"L33","DOI":"10.1152\/ajplung.2000.278.1.L33","volume":"278","author":"Taggart C","year":"2000","unstructured":"Taggart C, Coakely RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG. \n            Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8 \n            Am J Physiol Lung Cell Mol Physiol  \n            2000; \n            278\n            : L33-41.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V100.9.3383","volume":"100","author":"Coakley RJ","year":"2002","unstructured":"Coakley RJ, Taggart C, McElvaney NG, O'Neill SJ. \n            Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis \n            Blood  \n            2002; \n            100\n            : 3383-91.","journal-title":"Blood"},{"key":"refR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.4.2.191","volume":"4","author":"May TB","year":"1991","unstructured":"May TB, Shinabarger D, Maharaj R, et al. \n            Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients \n            Clin Microbiol Rev  \n            1991; \n            4\n            : 191-206.","journal-title":"Clin Microbiol Rev"},{"key":"refR12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35037627","volume":"407","author":"Singh PK","year":"2000","unstructured":"Singh PK, Schaefer AL, Paresk MR, Moninger TO, Welsh MJ, Greenberg EP. \n            Quorum sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms \n            Nature  \n            2000; \n            407\n            : 762-4.","journal-title":"Nature"},{"key":"refR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/iai.18.1.78-84.1977","volume":"18","author":"Bass DA","year":"1977","unstructured":"Bass DA, DeChatlet LR, Burk RF, Shirley P, Szedja P. \n            Polymorphonuclear leukocyte bactericidal activity and oxidative metabolism during glutathione peroxidase deficiency \n            Infect Immun  \n            1977; \n            18\n            : 78-84.","journal-title":"Infect Immun"},{"key":"refR14","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1164\/ajrccm\/150.6_Pt_2.S114","volume":"150","author":"Doring G","year":"1994","unstructured":"Doring G. \n            The role of neutrophil elastase in chronic inflammation \n            Am J Respir Crit Care Med  \n            1994; \n            150\n            : S114-117.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1203\/00006450-198612000-00014","volume":"20","author":"Fick PA","year":"1986","unstructured":"Fick PA, Robins RA, Squier SU, Schoderbek WE, Russ WD. \n            Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotatic activity \n            Pediatr Res  \n            1986; \n            20\n            : 1258-68.","journal-title":"Pediatr Res"},{"key":"refR16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI114298","volume":"84","author":"Berger M","year":"1989","unstructured":"Berger M, Soerensen RJ, Tosi MF, Dearborn DG, Doring G. \n            Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas infected lung in cystic fibrosis \n            J Clin Invest  \n            1989; \n            84\n            : 1302-.","journal-title":"J Clin Invest"},{"key":"refR17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1164\/rccm.200407-881PP","volume":"171","author":"Taggart CC","year":"2005","unstructured":"Taggart CC, Greene CM, Carroll TP, O'Neill SJ, McElvaney NG. \n            Elastolytic proteases: Inflammation resolution and dysregulation in chronic infective lung disease \n            Am J Respir Crit Care Med  \n            2005; \n            171\n            : 1070-6.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI0213572","volume":"109","author":"Vandivier RW","year":"2002","unstructured":"Vandivier RW, Fadok VA, Hoffmann PR, et al. \n            Elastase-mediated phosphatidylserine receptor cleavage impairs apopotic cell clearance in cystic fibrosis and bronchiectasis \n            J Clin Invest  \n            2002; \n            109\n            : 661-70.","journal-title":"J Clin Invest"},{"key":"refR19","doi-asserted-by":"crossref","first-page":"35494","DOI":"10.1074\/jbc.M103543200","volume":"276","author":"Walsh DE","year":"2001","unstructured":"Walsh DE, Greene CM, Carroll TP, et al. \n            Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88\/IRAK\/TRAF-6 in human bronchial epithelium \n            J Biol Chem  \n            2001; \n            276\n            : 35494-9.","journal-title":"J Biol Chem"},{"key":"refR20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/ajrccm\/146.6.1430","volume":"146","author":"Fahy JV","year":"1992","unstructured":"Fahy JV, Schuster A, Ueki I, Boushey HA, Nadel JA. \n            Mucus hypersecretion in bronchiestasis: the role of neutrophil proteases \n            Am Rev Respir Dis  \n            1992; \n            146\n            : 1430-3.","journal-title":"Am Rev Respir Dis"},{"key":"refR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(96)01508-6","volume":"402","author":"Ferry G","year":"1997","unstructured":"Ferry G, Longchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. \n            Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury \n            FEBS Lett  \n            1997; \n            402\n            : 111-5.","journal-title":"FEBS Lett"},{"key":"refR22","doi-asserted-by":"crossref","first-page":"16518","DOI":"10.1074\/jbc.270.28.16518","volume":"270","author":"Itoh Y","year":"1995","unstructured":"Itoh Y, Nagase H. \n            Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase \n            J Biol Chem  \n            1995; \n            270\n            : 16518-21.","journal-title":"J Biol Chem"},{"key":"refR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.10014","volume":"189","author":"Shamamian P","year":"2001","unstructured":"Shamamian P, Schwartz JD, Pocock BJ, et al. \n            Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis \n            J Cell Physiol  \n            2001; \n            189\n            : 197-206.","journal-title":"J Cell Physiol"},{"key":"refR24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.07-1631","volume":"133","author":"Elizur A","year":"2008","unstructured":"Elizur A, Cannon CL, Ferkol TW. \n            Airway inflammation in cystic fibrosis \n            Chest  \n            2008; \n            133\n            : 489-95.","journal-title":"Chest"},{"key":"refR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1165\/rcmb.4908","volume":"28","author":"Dulon S","year":"2003","unstructured":"Dulon S, Cande C, Bunnett NW, Hollenberg MD, Chignard M, Pidard D. \n            Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases \n            Am J Respir Cell Mol Biol  \n            2003; \n            28\n            : 339-46.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thx.2003.014902","volume":"59","author":"Rubio F","year":"2004","unstructured":"Rubio F, Cooley J, Accurso FJ, Remold-O'Donnell E. \n            Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease \n            Thorax  \n            2004; \n            59\n            : 318-23.","journal-title":"Thorax"},{"key":"refR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(94)00952-X","volume":"352","author":"Padrines M","year":"1994","unstructured":"Padrines M, Wolf M, Walz A, Baggiolini M. \n            Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3 \n            FEBS Lett  \n            1994; \n            352\n            : 231-5.","journal-title":"FEBS Lett"},{"key":"refR28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","volume":"96","author":"Van den Steen PE","year":"2000","unstructured":"Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. \n            Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact \n            Blood  \n            2000; \n            96\n            : 2673-81.","journal-title":"Blood"},{"key":"refR29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1165\/ajrcmb.20.4.3371","volume":"20","author":"Witko-Sarsat V","year":"1999","unstructured":"Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, et al. \n            Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum \n            Am J Respir Cell Mol Biol  \n            1999; \n            20\n            : 729-36.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","volume":"1","author":"Duranton J","year":"2003","unstructured":"Duranton J, Bieth JG. \n            Inhibition of proteinase 3 by [alpha] 1-antitrypsin in vitro predicts very fast inhibition in vivo \n            Am J Respir Cell Mol Biol  \n            2003; \n            1\n            : 57-61.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/014107689909237S05","volume":"92","author":"Balfour-Lynn IM","year":"1999","unstructured":"Balfour-Lynn IM. \n            The protease-antiprotease battle in the cystic fibrosis lung \n            J R Soc Med  \n            1999; \n            92\n            (Suppl 37)\n            : 23-30.","journal-title":"J R Soc Med"},{"key":"refR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1164\/ajrccm.150.1.7912987","volume":"150","author":"Birrer P","year":"1994","unstructured":"Birrer P, McElvaney N, R\u00fcderberg A, et al. \n            Protease-antiprotease imbalance in the lungs of children with cystic fibrosis \n            Am J Respir Crit Care Med  \n            1994; \n            150\n            : 207-13.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR33","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/infdis\/153.5.902","volume":"153","author":"Suter S","year":"1986","unstructured":"Suter S, Schaad UB, Tegner H, Ohlsson K, Desgrandchamps D, Waldvogel FA. \n            Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa \n            J Infect Dis  \n            1986; \n            153\n            : 902-.","journal-title":"J Infect Dis"},{"key":"refR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000467874","volume":"3","author":"Suter S","year":"1986","unstructured":"Suter S. \n            Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3 \n            Complement  \n            1986; \n            3\n            : 1-24.","journal-title":"Complement"},{"key":"refR35","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/bi00058a021","volume":"32","author":"Ying QL","year":"1993","unstructured":"Ying QL, Simon SR. \n            Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin \n            Biochemistry  \n            1993; \n            32\n            : 1866-74.","journal-title":"Biochemistry"},{"key":"refR36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb\/8.4.439","volume":"8","author":"Sallenave JM","year":"1993","unstructured":"Sallenave JM, Silva A. \n            Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions \n            Am J Respir Cell Mol Biol  \n            1993; \n            8\n            : 439-5.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR37","unstructured":"Burden RE, Scott CJ. \n            \n            Cysteine cathepsins in pulmonary diseases In: Taggart CC, Greene CM, Eds. \n            Mechanisms of pulmonary innate immunity.  \n            India: Research Signpost 2008; pp. \n            \n            \n            135-56."},{"key":"refR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.12.082","volume":"533","author":"Gueders MM","year":"2006","unstructured":"Gueders MM, Foidart JM, Noel A, Cataldo DD. \n            Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases \n            Eur J Pharmacol  \n            2006; \n            533\n            : 133-44.","journal-title":"Eur J Pharmacol"},{"key":"refR39","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1021\/bi00316a003","volume":"23","author":"Long GL","year":"1984","unstructured":"Long GL, Chandra T, Woo SL, Davie EW, Kurachi K. \n            Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant \n            Biochemistry  \n            1984; \n            23\n            : 4828-37.","journal-title":"Biochemistry"},{"key":"refR40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(88)90154-4","volume":"84","author":"Brantly M","year":"1988","unstructured":"Brantly M, Nukiwa T, Crystal RG. \n            Molecular basis of alpha-1-antitrypsin deficiency \n            Am J Med  \n            1988; \n            84\n            : 13-31.","journal-title":"Am J Med"},{"key":"refR41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.95.1.196","volume":"95","author":"Crystal RG","year":"1989","unstructured":"Crystal RG, Brantly ML, Hubbard RC, Curiel DT, States DJ, Holmes MD. \n            The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy \n            Chest  \n            1989; \n            95\n            : 196-208.","journal-title":"Chest"},{"key":"refR42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.bi.52.070183.003255","volume":"52","author":"Travis J","year":"1983","unstructured":"Travis J, Salvesen GS. \n            Human plasma proteinase inhibitors \n            Annu Rev Biochem  \n            1983; \n            52\n            : 655-709.","journal-title":"Annu Rev Biochem"},{"key":"refR43","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI112524","volume":"77","author":"Mornex JF","year":"1986","unstructured":"Mornex JF, Chytil-Weir A, Martinet Y, Courtney M, LeCocq JP, Crystal RG. \n            Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals \n            J Clin Invest  \n            1986; \n            77\n            : 1952-61.","journal-title":"J Clin Invest"},{"key":"refR44","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V77.12.2724.2724","volume":"77","author":"du Bois RM","year":"1991","unstructured":"du Bois RM, Bernaudin JF, Paakko P, et al. \n            Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin \n            Blood  \n            1991; \n            77\n            : 2724-30.","journal-title":"Blood"},{"key":"refR45","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","volume":"282","author":"Janciauskiene SM","year":"2007","unstructured":"Janciauskiene SM, Stevens T. \n            Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP \n            J Biol Chem  \n            2007; \n            282\n            : 8573-2.","journal-title":"J Biol Chem"},{"key":"refR46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrg907","volume":"3","author":"Lomas DA","year":"2002","unstructured":"Lomas DA, Carrell RW. \n            Serpinopathies and the conformational dementias \n            Nat Rev Genet  \n            2002; \n            3\n            : 759-68.","journal-title":"Nat Rev Genet"},{"key":"refR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0968-0004(97)01172-9","volume":"23","author":"Whisstock J","year":"1998","unstructured":"Whisstock J, Skinner R, Lesk AM. \n            An atlas of serpin conformations \n            Trends Biochem Sci  \n            1998; \n            23\n            : 63-7.","journal-title":"Trends Biochem Sci"},{"key":"refR48","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1084\/jem.167.5.1608","volume":"167","author":"Banda MJ","year":"1988","unstructured":"Banda MJ, Rice AG, Griffin GL, Senior RM. \n            The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant \n            J Exp Med  \n            1988; \n            167\n            : 1608-5.","journal-title":"J Exp Med"},{"key":"refR49","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/S0021-9258(19)85615-6","volume":"255","author":"Beatty K","year":"1980","unstructured":"Beatty K, Bieth J, Travis J. \n            Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin \n            J Biol Chem  \n            1980; \n            255\n            : 3931-4.","journal-title":"J Biol Chem"},{"key":"refR50","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0021-9258(18)50689-X","volume":"254","author":"Johnson D","year":"1979","unstructured":"Johnson D, Travis J. \n            The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center \n            J Biol Chem  \n            1979; \n            254\n            : 4022-6.","journal-title":"J Biol Chem"},{"key":"refR51","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","volume":"275","author":"Taggart C","year":"2000","unstructured":"Taggart C, Cervantes-Laurean D, Kim G, et al. \n            Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity \n            J Biol Chem  \n            2000; \n            275\n            : 27258-65.","journal-title":"J Biol Chem"},{"key":"refR52","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1021\/bi025599p","volume":"41","author":"Griffiths SW","year":"2002","unstructured":"Griffiths SW, Cooney CL. \n            Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin \n            Biochemistry  \n            2002; \n            41\n            : 6245-52.","journal-title":"Biochemistry"},{"key":"refR53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/ajrccm\/139.3.783","volume":"139","author":"Padrines M","year":"1989","unstructured":"Padrines M, Schneider-Pozzer M, Bieth JG. \n            Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils \n            Am Rev Respir Dis  \n            1989; \n            139\n            : 783-90.","journal-title":"Am Rev Respir Dis"},{"key":"refR54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0014-5793(87)80413-1","volume":"224","author":"Appelhans B","year":"1987","unstructured":"Appelhans B, Ender B, Sachse G, Nikiforov T, Appelhans H, Ebert W. \n            Secretion of antileucoprotease from a human lung tumor cell line \n            FEBS Lett  \n            1987; \n            224\n            : 14-8.","journal-title":"FEBS Lett"},{"key":"refR55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/37.4.2926127","volume":"37","author":"Franken C","year":"1989","unstructured":"Franken C, Meijer CJ, Dijkman JH. \n            Tissue distribution of antileukoprotease and lysozyme in humans \n            J Histochem Cytochem  \n            1989; \n            37\n            : 493-8.","journal-title":"J Histochem Cytochem"},{"key":"refR56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1432-1033.1986.tb09940.x","volume":"160","author":"Heinzel R","year":"1986","unstructured":"Heinzel R, Appelhans H, Gassen G, et al. \n            Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus \n            Eur J Biochem  \n            1986; \n            160\n            : 61-7.","journal-title":"Eur J Biochem"},{"key":"refR57","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/ajrccm\/147.3.710","volume":"147","author":"Lee CH","year":"1993","unstructured":"Lee CH, Igarashi Y, Hohman RJ, Kaulbach H, White MV, Kaliner MA. \n            Distribution of secretory leukoprotease inhibitor in the human nasal airway \n            Am Rev Respir Dis  \n            1993; \n            147\n            : 710-16.","journal-title":"Am Rev Respir Dis"},{"key":"refR58","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1093\/nar\/14.20.7883","volume":"14","author":"Stetler G","year":"1986","unstructured":"Stetler G, Brewer MT, Thompson RC. \n            Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases \n            Nucleic Acids Res  \n            1986; \n            14\n            : 7883-96.","journal-title":"Nucleic Acids Res"},{"key":"refR59","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","volume":"83","author":"Thompson RC","year":"1986","unstructured":"Thompson RC, Ohlsson K. \n            Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase \n            Proc Natl Acad Sci USA  \n            1986; \n            83\n            : 6692-.","journal-title":"Proc Natl Acad Sci USA"},{"key":"refR60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","volume":"368","author":"Clauss A","year":"2002","unstructured":"Clauss A, Lilja H, Lundwall A. \n            A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein \n            Biochem J  \n            2002; \n            368\n            : 233-42.","journal-title":"Biochem J"},{"key":"refR61","unstructured":"Weldon S, McGarry N, Taggart CC. \n            \n            SLPI and elafin: multifunctional components of the respiratory tract In: Taggart CC, Greene CM, Eds. \n            Mechanisms of pulmonary innate immunity.  \n            India: Research Signpost 2008; p. \n            \n            \n            201."},{"key":"refR62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.it.2008.07.001","volume":"29","author":"Bingle CD","year":"2008","unstructured":"Bingle CD, Vyakarnam A. \n            Novel innate immune functions of the whey acidic protein family \n            Trends Immunol  \n            2008; \n            29\n            : 444-53.","journal-title":"Trends Immunol"},{"key":"refR63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biochi.2007.09.007","volume":"90","author":"Moreau T","year":"2008","unstructured":"Moreau T, Baranger K, Dad\u00e9 S, Dallet-Choisy S, Guyot N, Zani ML. \n            Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family \n            Biochimie  \n            2008; \n            90\n            : 284-95.","journal-title":"Biochimie"},{"key":"refR64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/BST0340279","volume":"34","author":"Fitch PM","year":"2006","unstructured":"Fitch PM, Roghanian A, Howie SE, Sallenave JM. \n            Human neutrophil elastase inhibitors in innate and adaptive immunity \n            Biochem Soc Trans  \n            2006; \n            34\n            : 279-82.","journal-title":"Biochem Soc Trans"},{"key":"refR65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/CS20050115","volume":"110","author":"Williams SE","year":"2006","unstructured":"Williams SE, Brown TI, Roghanian A, Sallenave JM. \n            SLPI and elafin: one glove, many fingers \n            Clin Sci (Lond)  \n            2006; \n            110\n            : 21-35.","journal-title":"Clin Sci (Lond)"},{"key":"refR66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0092-8674(00)81880-2","volume":"88","author":"Jin FY","year":"1997","unstructured":"Jin FY, Nathan C, Radzioch D, Ding A. \n            Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide \n            Cell  \n            1997; \n            88\n            : 417-26.","journal-title":"Cell"},{"key":"refR67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jlb.61.6.695","volume":"61","author":"Sallenave JM","year":"1997","unstructured":"Sallenave JM, Si-Ta Har M, Cox G, Chignard M, Gauldie J. \n            Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils \n            J Leukoc Biol  \n            1997; \n            61\n            : 695-702.","journal-title":"J Leukoc Biol"},{"key":"refR68","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1165\/ajrcmb\/8.6.612","volume":"8","author":"Rao NV","year":"1993","unstructured":"Rao NV, Marshall BC, Gray BH, Hoidal JR. \n            Interaction of secretory leukocyte protease inhibitor with proteinase-3 \n            Am J Respir Cell Mol Biol  \n            1993; \n            8\n            : 612-16.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1465-9921-7-29","volume":"7","author":"Rogan MP","year":"2006","unstructured":"Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG. \n            Antimicrobial proteins and polypeptides in pulmonary innate defence \n            Respir Res  \n            2006; \n            7\n            : 29.","journal-title":"Respir Res"},{"key":"refR70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20021824","volume":"197","author":"Nakamura A","year":"2003","unstructured":"Nakamura A, Mori Y, Hagiwara K, et al. \n            Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice \n            J Exp Med  \n            2003; \n            197\n            : 669-74.","journal-title":"J Exp Med"},{"key":"refR71","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9440(10)65270-4","volume":"154","author":"Lentsch AB","year":"1999","unstructured":"Lentsch AB, Jordan JA, Czermak BJ, et al. \n            Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation \n            Am J Pathol  \n            1999; \n            154\n            : 239-47.","journal-title":"Am J Pathol"},{"key":"refR72","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0002-9440(10)64971-1","volume":"156","author":"Mulligan MS","year":"2000","unstructured":"Mulligan MS, Lentsch AB, Huber-Lang M, et al. \n            Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor \n            Am J Pathol  \n            2000; \n            156\n            : 1033-9.","journal-title":"Am J Pathol"},{"key":"refR73","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20050768","volume":"202","author":"Taggart CC","year":"2005","unstructured":"Taggart CC, Cryan SA, Weldon S, et al. \n            Secretory leukocyte protease inhibitor binds to NF-{kappa}B binding sites in monocytes and inhibits p65 binding \n            J Exp Med  \n            2005; \n            202\n            : 1659-68.","journal-title":"J Exp Med"},{"key":"refR74","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/377238","volume":"188","author":"Greene C","year":"2003","unstructured":"Greene C, Taggart C, Lowe G, Gallagher P, McElvaney N, O'Neill S. \n            Local impairment of anti-neutrophil elastase capacity in community acquired pneumonia \n            J Infect Dis  \n            2003; \n            188\n            : 769-.","journal-title":"J Infect Dis"},{"key":"refR75","doi-asserted-by":"crossref","first-page":"33648","DOI":"10.1074\/jbc.M203710200","volume":"277","author":"Taggart CC","year":"2002","unstructured":"Taggart CC, Greene CM, McElvaney NG, O'Neill S. \n            Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination \n            J Biol Chem  \n            2002; \n            277\n            : 33648-53.","journal-title":"J Biol Chem"},{"key":"refR76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1460-2075.1988.tb02819.x","volume":"7","author":"Grutter MG","year":"1988","unstructured":"Grutter MG, Fendrich G, Huber R, Bode W. \n            The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucus secretions analysed in its complex with bovine alphachymotrypsin \n            EMBO J  \n            1988; \n            7\n            : 345-51.","journal-title":"EMBO J"},{"key":"refR77","first-page":"677","volume":"50","author":"Heinzel-Wieland R","year":"1991","unstructured":"Heinzel-Wieland R, Steffens GJ, Flohe L. \n            Inhibitory characteristics and oxidant resistance of site specific variants of recombinant human antileukoproteinase (ALP) \n            Biomed Biochim Acta  \n            1991; \n            50\n            : 677-81.","journal-title":"Biomed Biochim Acta"},{"key":"refR78","doi-asserted-by":"crossref","first-page":"33345","DOI":"10.1074\/jbc.M103220200","volume":"276","author":"Taggart CC","year":"2001","unstructured":"Taggart CC, Lowe GJ, Greene CM, et al. \n            Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor \n            J Biol Chem  \n            2001; \n            276\n            : 33345-52.","journal-title":"J Biol Chem"},{"key":"refR79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/bchm3.1991.372.1.13","volume":"372","author":"Sallenave JM","year":"1991","unstructured":"Sallenave JM, Ryle AP. \n            Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor \n            Biol Chem Hoppe Seyler  \n            1991; \n            372\n            : 13-21.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"refR80","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1016\/S0021-9258(19)50303-9","volume":"268","author":"Molhuizen HO","year":"1993","unstructured":"Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J. \n            SKALP\/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking \n            J Biol Chem  \n            1993; \n            268\n            : 12028-32.","journal-title":"J Biol Chem"},{"key":"refR81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0021-9150(01)00542-1","volume":"160","author":"Sumi Y","year":"2002","unstructured":"Sumi Y, Inoue N, Azumi H, et al. \n            Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability \n            Atherosclerosis  \n            2002; \n            160\n            : 31-9.","journal-title":"Atherosclerosis"},{"key":"refR82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/znc-2001-3-420","volume":"56","author":"Mihaila A","year":"2001","unstructured":"Mihaila A, Tremblay GM. \n            Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor \n            Z Naturforsch [C]  \n            2001; \n            56\n            : 291-7.","journal-title":"Z Naturforsch [C]"},{"key":"refR83","first-page":"4631","volume":"57","author":"Zhang M","year":"1997","unstructured":"Zhang M, Magit D, Pardee AB, Sager R. \n            Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoter \n            Cancer Res  \n            1997; \n            57\n            : 4631-6.","journal-title":"Cancer Res"},{"key":"refR84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1165\/ajrcmb.25.1.4341","volume":"25","author":"Bingle L","year":"2001","unstructured":"Bingle L, Tetley TD, Bingle CD. \n            Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-kappaB \n            Am J Respir Cell Mol Biol  \n            2001; \n            25\n            : 84-91.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1165\/ajrcmb.24.1.4300","volume":"24","author":"Ying QL","year":"2001","unstructured":"Ying QL, Simon SR. \n            Kinetics of the inhibition of proteinase 3 by elafin \n            Am J Respir Cell Mol Biol  \n            2001; \n            24\n            : 83-9.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR86","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.167.3.1778","volume":"167","author":"Simpson AJ","year":"2001","unstructured":"Simpson AJ, Wallace WA, Marsden ME, et al. \n            Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection \n            J Immunol  \n            2001; \n            167\n            : 1778-86.","journal-title":"J Immunol"},{"key":"refR87","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1515\/BC.2002.138","volume":"383","author":"Vachon E","year":"2002","unstructured":"Vachon E, Bourbonnais Y, Bingle CD, Rowe SJ, Janelle MF, Tremblay GM. \n            Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation \n            Biol Chem  \n            2002; \n            383\n            : 1249-56.","journal-title":"Biol Chem"},{"key":"refR88","doi-asserted-by":"crossref","first-page":"32377","DOI":"10.1074\/jbc.M803707200","volume":"283","author":"Guyot N","year":"2008","unstructured":"Guyot N, Butler MW, McNally P, et al. \n            Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis \n            J Biol Chem  \n            2008; \n            283\n            : 32377-85.","journal-title":"J Biol Chem"},{"key":"refR89","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1164\/rccm.200202-098OC","volume":"166","author":"Wright JL","year":"2002","unstructured":"Wright JL, Farmer SG, Churg A. \n            Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs \n            Am J Respir Crit Care Med  \n            2002; \n            166\n            : 954-60.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR90","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(98)00028-4","volume":"345","author":"Shinguh Y","year":"1998","unstructured":"Shinguh Y, Yamazaki A, Inamura N, et al. \n            Biochemical and pharmacological characterization of FR134043, a novel elastase inhibitor \n            Eur J Pharmacol  \n            1998; \n            345\n            : 299-308.","journal-title":"Eur J Pharmacol"},{"key":"refR91","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.1991.tb17022.x","volume":"624","author":"Williams JC","year":"1991","unstructured":"Williams JC, Stein RL, Giles RE, Krell RD. \n            Biochemistry and pharmacology of ICI 200, 880, a synthetic peptide inhibitor of human neutrophil elastase \n            Ann N Y Acad Sci  \n            1991; \n            624\n            : 230-43.","journal-title":"Ann N Y Acad Sci"},{"key":"refR92","first-page":"918","volume":"114","author":"Tarjan E","year":"1984","unstructured":"Tarjan E, Peto L, Appel J, Tolnay P. \n            Protective effect of specific elastase inhibitor in experimental pulmonary emphysema \n            Schweiz Med Wochenschr  \n            1984; \n            114\n            : 918-20.","journal-title":"Schweiz Med Wochenschr"},{"key":"refR93","first-page":"539","volume":"135","author":"Wewers MD","year":"1987","unstructured":"Wewers MD, Casolaro MA, Crystal RG. \n            Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy \n            Am Rev Respir Dis  \n            1987; \n            135\n            : 539-43.","journal-title":"Am Rev Respir Dis"},{"key":"refR94","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jama.1988.03410090091037","volume":"260","author":"Hubbard RC","year":"1988","unstructured":"Hubbard RC, Sellers S, Czerski D, Stephens L, Crystal RG. \n            Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency \n            JAMA  \n            1988; \n            260\n            : 1259-64.","journal-title":"JAMA"},{"key":"refR95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09674845.2004.11732661","volume":"61","author":"Moore JE","year":"2004","unstructured":"Moore JE, Shaw A, Millar BC, et al. \n            Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients \n            Br J Biomed Sci  \n            2004; \n            61\n            (3)\n            : 146-7.","journal-title":"Br J Biomed Sci"},{"key":"refR96","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ppul.20345","volume":"2","author":"Martin SL","year":"2006","unstructured":"Martin SL, Downey D, Bilton D, Keogan MT, Edgar J, Elborn JS. \n            Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis \n            Pediatr Pulmonol  \n            2006; \n            2\n            : 177-83.","journal-title":"Pediatr Pulmonol"},{"key":"refR97","first-page":"201","volume":"4","author":"Cantin AM","year":"2006","unstructured":"Cantin AM, Berthiaume Y, Cloutier D, Martel M. \n            Prolastin aerosol therapy and sputum taurine in cystic fibrosis \n            Clin Invest Med  \n            2006; \n            4\n            : 201-7.","journal-title":"Clin Invest Med"},{"key":"refR98","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00047306","volume":"2","author":"Griese M","year":"2007","unstructured":"Griese M, Latzin P, Kappler M, et al. \n            alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients \n            Eur Respir J  \n            2007; \n            2\n            : 240-50.","journal-title":"Eur Respir J"},{"key":"refR99","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.00118408","volume":"34","author":"Brand P","year":"2009","unstructured":"Brand P, Schulte M, Wencker M, et al. \n            Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency \n            Eur Respir J  \n            2009; \n            34\n            (2)\n            : 354-60.","journal-title":"Eur Respir J"},{"key":"refR100","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1164\/rccm.200209-1119OC","volume":"167","author":"Ferkol T","year":"2003","unstructured":"Ferkol T, Cohn LA, Phillips TE, Smith A, Davis PB. \n            Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts \n            Am J Respir Crit Care Med  \n            2003; \n            167\n            : 1374-9.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01870987","volume":"110","author":"Cereijido M","year":"1989","unstructured":"Cereijido M, Ponce A, Gonzalez-Marical J. \n            Tight junctions and apical basolateral polarity \n            J Membr Biol  \n            1989; \n            110\n            : 1-9.","journal-title":"J Membr Biol"},{"key":"refR102","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI115994","volume":"90","author":"McElvaney NG","year":"1992","unstructured":"McElvaney NG, Nakamura H, Birrer P, et al. \n            Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor \n            J Clin Invest  \n            1992; \n            90\n            : 1296-301.","journal-title":"J Clin Invest"},{"key":"refR103","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1164\/ajrccm\/148.4_Pt_1.1056","volume":"148","author":"McElvaney NG","year":"1993","unstructured":"McElvaney NG, Doujaiji B, Moan MJ, Burnham MR, Wu MC, Crystal RG. \n            Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis \n            Am Rev Respir Dis  \n            1993; \n            148\n            : 1056-60.","journal-title":"Am Rev Respir Dis"},{"key":"refR104","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1152\/jappl.1993.75.2.825","volume":"75","author":"Gillissen A","year":"1993","unstructured":"Gillissen A, Birrer P, McElvaney NG, et al. \n            Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid \n            J Appl Physiol  \n            1993; \n            75\n            : 825-32.","journal-title":"J Appl Physiol"},{"key":"refR105","unstructured":"Proteo Biotech AG. \n            Available from: www.proteo.de\/framesets\/r-and-d.php?lang=en  \n             [Accessed: October 26, 2009];"},{"key":"refR106","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/089426803321919889","volume":"16","author":"Grimbert D","year":"2003","unstructured":"Grimbert D, Vecellio L, Del\u00e9pine P, et al. \n            Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosis \n            J Aerosol Med  \n            2003; \n            16\n            (2)\n            : 121-9.","journal-title":"J Aerosol Med"},{"key":"refR107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/jpet.106.103440","volume":"318","author":"Attucci S","year":"2006","unstructured":"Attucci S, Gauthier A, Korkmaz B, et al. \n            EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis \n            J Pharmacol Exp Ther  \n            2006; \n            318\n            (2)\n            : 803-9.","journal-title":"J Pharmacol Exp Ther"},{"key":"refR108","unstructured":"Ono Pharmaceutical Co., Ltd. \n            Available from: http:\/\/www.ono.co.jp\/eng\/default. htm  \n             [Accessed: October 26, 2009];"},{"key":"refR109","first-page":"170","volume":"1","author":"Wolters PJ","year":"2001","unstructured":"Wolters PJ, Chapman HA. \n            Importance of lysosomal cysteine proteases in lung disease \n            Respir Res  \n            2001; \n            1\n            : 170-7.","journal-title":"Respir Res"},{"key":"refR110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1183\/09031936.04.00105304","volume":"23","author":"B\u00fchling F","year":"2004","unstructured":"B\u00fchling F, Waldburg N, Reisenauer A, Heimburg A, Golpon H, Welte T. \n            Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation \n            Eur Respir J  \n            2004; \n            23\n            : 620-8.","journal-title":"Eur Respir J"},{"key":"refR111","doi-asserted-by":"crossref","first-page":"295S","DOI":"10.1378\/chest.117.5_suppl_1.295S","volume":"117","author":"Chapman HA","year":"2000","unstructured":"Chapman HA Jr, Shi GP. \n            Protease injury in the development of COPD: Thomas A. Neff Lecture \n            Chest  \n            2000; \n            117\n            : 295S-99S.","journal-title":"Chest"},{"key":"refR112","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1165\/ajrcmb.20.4.3405","volume":"20","author":"B\u00fchling F","year":"1999","unstructured":"B\u00fchling F, Gerber A, H\u00e4ckel C, et al. \n            Expression of cathepsin K in lung epithelial cells \n            Am J Respir Cell Mol Biol  \n            1999; \n            20\n            : 612-19.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR113","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1016\/S0021-9258(18)42513-6","volume":"267","author":"Shi GP","year":"1992","unstructured":"Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA. \n            Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease \n            J Biol Chem  \n            1992; \n            267\n            : 7258-62.","journal-title":"J Biol Chem"},{"key":"refR114","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1165\/ajrcmb.26.6.4744","volume":"26","author":"Brasch F","year":"2002","unstructured":"Brasch F, Ten Brinke A, Johnen G, et al. \n            Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes \n            Am J Respir Cell Mol Biol  \n            2002; \n            26\n            : 659-70.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"refR115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0076-6879(94)44036-0","volume":"244","author":"Kirschke H","year":"1994","unstructured":"Kirschke H, Wiederanders B. \n            Cathepsin S and related lysosomal endopeptidases \n            Methods Enzymol  \n            1994; \n            244\n            : 500-11.","journal-title":"Methods Enzymol"},{"key":"refR116","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1074\/jbc.273.25.15514","volume":"273","author":"Wolters PJ","year":"1998","unstructured":"Wolters PJ, Raymond WW, Blount JL, Caughey GH. \n            Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I \n            J Biol Chem  \n            1998; \n            273\n            : 15514-20.","journal-title":"J Biol Chem"},{"key":"refR117","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/thorax.57.11.926","volume":"57","author":"Tate S","year":"2002","unstructured":"Tate S, MacGregor G, Davis M, Innes JA, Greening AP. \n            Airways in cystic fibrosis are acidified: detection by exhaled breath condensate \n            Thorax  \n            2002; \n            57\n            : 926-.","journal-title":"Thorax"},{"key":"refR118","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.4049\/jimmunol.178.9.5871","volume":"178","author":"Geraghty P","year":"2007","unstructured":"Geraghty P, Rogan MP, Greene CM, et al. \n            Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression \n            J Immunol  \n            2007; \n            178\n            : 5871-8.","journal-title":"J Immunol"},{"key":"refR119","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/abbi.1995.1167","volume":"317","author":"Burnett D","year":"1995","unstructured":"Burnett D, Abrahamson M, Devalia JL, Sapsford RJ, Davies RJ, Buttle DJ. \n            Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase \n            Arch Biochem Biophys  \n            1995; \n            317\n            : 305-10.","journal-title":"Arch Biochem. Biophys"},{"key":"refR120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","volume":"171","author":"Taggart CC","year":"2003","unstructured":"Taggart CC, Greene CM, Smith SG, et al. \n            Inactivation of human \u03b2-defensins 2 and 3 by elastolytic cathepsins \n            J Immunol  \n            2003; \n            171\n            : 931-7.","journal-title":"J Immunol"},{"key":"refR121","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","volume":"190","author":"Rogan MP","year":"2004","unstructured":"Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. \n            Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis \n            J Infect Dis  \n            2004; \n            190\n            : 1245-53.","journal-title":"J Infect Dis"},{"key":"refR122","first-page":"175","volume":"28","author":"L\u00e1szl\u00f3 A","year":"1987","unstructured":"L\u00e1szl\u00f3 A, Soh\u00e1r I, Gyurkovits K. \n            Activity of the lysosomal cysteine proteinases (cathepsin B,H,L) and a metalloproteinase (MMP-7-ase) in the serum of cystic fibrosis homozygous children \n            Acta Paediatr Hung  \n            1987; \n            28\n            : 175-8.","journal-title":"Acta Paediatr Hung"},{"key":"refR123","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/S0021-9258(18)53798-4","volume":"268","author":"McGuire MJ","year":"1993","unstructured":"McGuire MJ, Lipsky PE, Thiele DL. \n            Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I \n            J Biol Chem  \n            1993; \n            268\n            : 2458-67.","journal-title":"J Biol Chem"},{"key":"refR124","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1074\/jbc.270.5.2218","volume":"270","author":"Murakami M","year":"1995","unstructured":"Murakami M, Karnik SS, Husain A. \n            Human prochymase activation. A novel role for heparin in zymogen processing \n            J Biol Chem  \n            1995; \n            270\n            : 2218-3.","journal-title":"J Biol Chem"},{"key":"refR125","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","volume":"96","author":"Pham CT","year":"1999","unstructured":"Pham CT, Ley TJ. \n            Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo \n            Proc Natl Acad Sci USA  \n            1999; \n            96\n            : 8627-32.","journal-title":"Proc Natl Acad Sci USA"},{"key":"refR126","doi-asserted-by":"crossref","first-page":"14748","DOI":"10.1016\/S0021-9258(18)66935-2","volume":"261","author":"Johnson DA","year":"1986","unstructured":"Johnson DA, Barrett AJ, Mason RW. \n            Cathepsin L inactivates alpha 1-proteinase inhibitor by cleavage in the reactive site region \n            J Biol Chem  \n            1986; \n            261\n            : 14748-51.","journal-title":"J Biol Chem"},{"key":"refR127","first-page":"587","volume":"50","author":"Abrahamson M","year":"1991","unstructured":"Abrahamson M, Buttle DJ, Mason RW, et al. \n            Regulation of cystatin C activity by serine proteinases \n            Biomed Biochim Acta  \n            1991; \n            50\n            : 587-93.","journal-title":"Biomed Biochim Acta"},{"key":"refR128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","volume":"13","author":"Vasiljeva O","year":"2007","unstructured":"Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. \n            Emerging roles of cysteine cathepsins in disease and their potential as drug targets \n            Curr Pharm Des  \n            2007; \n            13\n            : 387-40.","journal-title":"Curr Pharm Des"},{"key":"refR129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"Sternlicht MD","year":"2001","unstructured":"Sternlicht MD, Werb Z. \n            How matrix metalloproteinases regulate cell behavior \n            Annu Rev Cell Dev Biol  \n            2001; \n            17\n            : 463-516.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"refR130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","volume":"4","author":"Parks WC","year":"2004","unstructured":"Parks WC, Wilson CL, Lopez-Boado YS. \n            Matrix metalloproteinases as modulators of inflammation and innate immunity \n            Nat Rev Immunol  \n            2004; \n            4\n            : 617-29.","journal-title":"Nat Rev Immunol"},{"key":"refR131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.21044","volume":"44","author":"Peterson-Carmichael SL","year":"2009","unstructured":"Peterson-Carmichael SL, Harris WT, Goel R, et al. \n            Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis \n            Pediatr Pulmonol  \n            2009; \n            44\n            : 503-11.","journal-title":"Pediatr Pulmonol"},{"key":"refR132","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thorax.57.11.930","volume":"57","author":"Ratjen F","year":"2002","unstructured":"Ratjen F, Hartog CM, Paul K, Wermelt J, Braun J. \n            Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha \n            Thorax  \n            2002; \n            57\n            : 930-4.","journal-title":"Thorax"},{"key":"refR133","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/thx.2006.074641","volume":"62","author":"Hilliard TN","year":"2007","unstructured":"Hilliard TN, Regamey N, Shute JK, et al. \n            Airway remodelling in children with cystic fibrosis \n            Thorax  \n            2007; \n            62\n            : 1074-80.","journal-title":"Thorax"},{"key":"refR134","doi-asserted-by":"crossref","first-page":"L96","DOI":"10.1152\/ajplung.00492.2006","volume":"293","author":"Gaggar A","year":"2007","unstructured":"Gaggar A, Li Y, Weathington N, et al. \n            Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients \n            Am J Physiol Lung Cell Mol Physiol  \n            2007; \n            293\n            : L96-L104.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"refR135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ppul.20165","volume":"39","author":"Sagel SD","year":"2005","unstructured":"Sagel SD, Kapsner RK, Osberg I. \n            Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis \n            Pediatr Pulmonol  \n            2005; \n            39\n            : 224-32.","journal-title":"Pediatr Pulmonol"},{"key":"refR136","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(96)01508-6","volume":"402","author":"Ferry G","year":"1997","unstructured":"Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. \n            Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury \n            FEBS Lett  \n            1997; \n            402\n            : 111-5.","journal-title":"FEBS Lett"},{"key":"refR137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","volume":"19","author":"Manicone AM","year":"2008","unstructured":"Manicone AM, McGuire JK. \n            Matrix metalloproteinases as modulators of inflammation \n            Semin Cell Dev Biol  \n            2008; \n            19\n            : 34-41.","journal-title":"Semin Cell Dev Biol"},{"key":"refR138","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1172\/JCI115262","volume":"87","author":"Desrochers PE","year":"1991","unstructured":"Desrochers PE, Jeffrey JJ, Weiss SJ. \n            Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity \n            J Clin Invest  \n            1991; \n            87\n            : 2258-65.","journal-title":"J Clin Invest"},{"key":"refR139","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0304-4165(94)90119-8","volume":"1199","author":"Zhang Z","year":"1994","unstructured":"Zhang Z, Winyard PG, Chidwick K, et al. \n            Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin \n            Biochim Biophys Acta  \n            1994; \n            1199\n            : 224-8.","journal-title":"Biochim Biophys Acta"},{"key":"refR140","first-page":"80","volume":"1","author":"Michaelis J","year":"1992","unstructured":"Michaelis J, Vissers MC, Winterbourn CC. \n            Cleavage of alpha 1-antitrypsin by human neutrophil collagenase \n            Matrix Suppl  \n            1992; \n            1\n            : 80-1.","journal-title":"Matrix Suppl"},{"key":"refR141","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0092-8674(00)00087-8","volume":"102","author":"Liu Z","year":"2000","unstructured":"Liu Z, Zhou X, Shapiro SD, et al. \n            The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 S \n            Cell  \n            2000; \n            102\n            : 647-55.","journal-title":"Cell"},{"key":"refR142","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0002-9440(10)63589-4","volume":"163","author":"Shapiro SD","year":"2003","unstructured":"Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. \n            Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice \n            Am J Pathol  \n            2003; \n            163\n            : 2329-35.","journal-title":"Am J Pathol"},{"key":"refR143","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.182.3.1560","volume":"182","author":"Ramadas RA","year":"2009","unstructured":"Ramadas RA, Wu L, LeVine AM. \n            Surfactant protein A enhances production of secretory leukoprotease inhibitor and protects it from cleavage by matrix metalloproteinases \n            J Immunol  \n            2009; \n            182\n            : 1560-7.","journal-title":"J Immunol"},{"key":"refR144","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/019021402753462022","volume":"28","author":"Henry MT","year":"2002","unstructured":"Henry MT, McMahon K, Costello C, Fitzgerald MX, O'Connor CM. \n            Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8 \n            Exp Lung Res  \n            2002; \n            28\n            : 85-97.","journal-title":"Exp Lung Res"},{"key":"refR145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00428-009-0748-4","volume":"454","author":"Dijkstra A","year":"2009","unstructured":"Dijkstra A, Postma DS, Noordhoek JA, et al. \n            Expression of ADAMs (\"a disintegrin and metalloprotease\") in the human lung \n            Virchows Arch  \n            2009; \n            454\n            : 441-9.","journal-title":"Virchows Arch"},{"key":"refR146","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.4049\/jimmunol.175.6.4009","volume":"175","author":"Shao MX","year":"2005","unstructured":"Shao MX, Nadel JA. \n            Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme \n            J Immunol  \n            2005; \n            175\n            : 4009-16.","journal-title":"J Immunol"},{"key":"refR147","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1074\/jbc.M208326200","volume":"278","author":"Thathiah A","year":"2003","unstructured":"Thathiah A, Blobel CP, Carson DD. \n            Tumor necrosis factor-alpha converting enzyme\/ADAM 17 mediates MUC1 shedding \n            J Biol Chem  \n            2003; \n            278\n            : 3386-94.","journal-title":"J Biol Chem"},{"key":"refR148","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20040513","volume":"362","author":"Thathiah A","year":"2004","unstructured":"Thathiah A, Carson DD. \n            MT1-MMP mediates MUC1 shedding independently of TACE\/ADAM17 \n            Biochem J  \n            2004; \n            362\n            : 363-73.","journal-title":"Biochem J"},{"key":"refR149","doi-asserted-by":"crossref","first-page":"L181","DOI":"10.1152\/ajplung.2001.280.1.L181","volume":"280","author":"Lillehoj EP","year":"2001","unstructured":"Lillehoj EP, Hyun SW, Kim BT, et al. \n            Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa \n            Am J Physiol Lung Cell Mol Physiol  \n            2001; \n            280\n            : L181-7.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"refR150","doi-asserted-by":"crossref","first-page":"17369","DOI":"10.1074\/jbc.M600509200","volume":"281","author":"Vij N","year":"2006","unstructured":"Vij N, Fang S, Zeitlin PL. \n            Selective inhibition of endoplasmic reticulum-associated degradation rescues F508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels \n            J Biol Chem  \n            2006; \n            281\n            : 17369-78.","journal-title":"J Biol Chem"},{"key":"refR151","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","volume":"83","author":"Ward CL","year":"1995","unstructured":"Ward CL, Omura S, Kopito RR. \n            Degradation of CFTR by the ubiquitin-proteasome pathway \n            Cell  \n            1995; \n            83\n            : 121-7.","journal-title":"Cell"},{"key":"refR152","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1056\/NEJMp030092","volume":"348","author":"Mitchell BS","year":"2003","unstructured":"Mitchell BS. \n            A phase 2 study of bortezomib in relapsed refractory myeloma \n            N Eng J Med  \n            2003; \n            348\n            : 2597-8.","journal-title":"N Eng J Med"},{"key":"refR153","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-4838(99)00278-2","volume":"1477","author":"Travis J","year":"2000","unstructured":"Travis J, Potempa J. \n            Bacterial proteinases as targets for the development of second-generation antibiotics \n            Biochimica Biophysica Acta  \n            2000; \n            1477\n            : 35-50.","journal-title":"Biochimica Biophysica Acta"},{"key":"refR154","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-2958.1998.01121.x","volume":"30","author":"Kamath S","year":"1998","unstructured":"Kamath S, Kapatral V, Chakrabarty AM. \n            Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside disphosphate kinase and in alginate synthesis \n            Mol Microbiol  \n            1998; \n            30\n            : 933-41.","journal-title":"Mol Microbiol"},{"key":"refR155","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1128\/IAI.00015-07","volume":"75","author":"Leduc D","year":"2007","unstructured":"Leduc D, Beaufort N, de Bentzmann S, et al. \n            The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis \n            Infect Immun  \n            2007; \n            75\n            (8)\n            : 3848-58.","journal-title":"Infect Immun"},{"key":"refR156","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/mr.60.3.539-574.1996","volume":"660","author":"Govan JRW","year":"1996","unstructured":"Govan JRW, Deretic V. \n            Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia \n            Microbiol Rev  \n            1996; \n            660\n            : 539-74.","journal-title":"Microbiol Rev"}],"container-title":["The Open Respiratory Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V4\/TORMJ-4-20\/TORMJ-4-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V4\/TORMJ-4-20\/TORMJ-4-20.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V4\/TORMJ-4-20\/TORMJ-4-20.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:10:24Z","timestamp":1739167824000},"score":1,"resource":{"primary":{"URL":"https:\/\/openrespiratorymedicinejournal.com\/VOLUME\/4\/PAGE\/20\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":156,"journal-issue":{"issue":"01","published-print":{"date-parts":[[2010,3,30]]}},"alternative-id":["TORMJ-4-20"],"URL":"https:\/\/doi.org\/10.2174\/1874306401004020020","relation":{},"ISSN":["1874-3064"],"issn-type":[{"value":"1874-3064","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2009-7-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-10-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-10-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-03-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}